Disclaimer: This site is a part of curriculum project. The information should be used for educational purpose only.
ONGOING RESEARCHES IN CANCER TREATMENT AND DRUG DESIGN
1. Drug insight: histone deacetylase inhibitors--development of the new targeted anticancer agent suberoylanilide hydroxamic acid
WK Kelly, PA Marks - Nature Clinical Practice Oncology, 2005 - nature.com
2. Polymer conjugates as anticancer nanomedicines
R Duncan - Nature Reviews Cancer, 2006 - nature.com
3. Proteasome inhibitors: antitumor effects and beyond
A Nencioni, F Grünebach, F Patrone, A Ballestrero… - Leukemia, 2007 - nature.com
4. Anticancer activities of histone deacetylase inhibitors
JE Bolden, MJ Peart, RW Johnstone - Nature reviews Drug discovery, 2006 - nature.com
5. Targeting the mitogen-activated protein kinase cascade to treat cancer
JS Sebolt-Leopold, R Herrera - Nature Reviews Cancer, 2004 - nature.com
6. Discovery and development of sorafenib: a multikinase inhibitor for treating cancer
S Wilhelm, C Carter, M Lynch, T Lowinger… - … reviews Drug discovery, 2006 - nature.com
7. Novel anticancer targets: revisiting ERBB2 and discovering ERBB3
J Baselga, SM Swain - Nature Reviews Cancer, 2009 - nature.com
8. Envisioning the future of early anticancer drug development
TA Yap, SK Sandhu, P Workman, JS de Bono - Nature Reviews Cancer, 2010 - nature.com
Further research references: International Journal of cancer research and Treatment , march 2015
http://ar.iiarjournals.org/content/current